To determine whether sEH inhibition modulates T lymphocytes in the TME, we performed flow cytometry on established MB49 bladder tumors treated with EC5026 or ICI (anti-PD-1) for 7 d. This evidence concerns the gene EPHX2 and urinary bladder neoplasm.